Three different methodologies have been applied to microarray data from brains of Alzheimer diagnosed patients and healthy patients taken as control. A clear pattern of differential gene expression results which can be regarded as a molecular signature of the disease. The results show the complementarity of the different methodologies, suggesting that a unified approach may help to uncover complex genetic risk factors not currently discovered with a single method. We also compare the set of genes in these differential patterns with those already reported in the literature.
Applications on Evolutionary Computing: EvoWorkkshops 2005: EvoBIO, EvoCOMNET, EvoHOT, EvoIASP, EvoMUSART, and EvoSTOC. (Lausanne, Switzerland 30 March - 1 April, 2005)